X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-03-05 | CERS | Cerus Corp | Green Kevin Dennis | CFO | S - Sale | $2.04 | -83,021 | 1,168,095 | -7% | -$169,646 | |||||
| M | 2026-03-05 | CERS | Cerus Corp | Benjamin Richard J | Chief Medical Officer | S - Sale | $1.99 | -125,894 | 879,101 | -13% | -$250,938 | |||||
2026-03-06 | CERS | Cerus Corp | Jensen Chrystal | GC | S - Sale | $2.01 | -30,845 | 1,059,139 | -3% | -$61,860 | ||||||
2026-03-06 | CERS | Cerus Corp | Jayaraman Vivek K | COO | S - Sale | $2.01 | -34,094 | 1,912,874 | -2% | -$68,376 | ||||||
2026-03-06 | CERS | Cerus Corp | Greenman William Mariner | Pres, CEO | S - Sale | $2.01 | -78,187 | 5,446,250 | -1% | -$156,804 | ||||||
| M | 2026-03-05 | PRCT | Procept Biorobotics Corp | Desai Antal Rohit | Dir | P - Purchase | $24.59 | +426,262 | 475,777 | +861% | +$10,482,943 | |||||
| D | 2026-03-06 | PRCT | Procept Biorobotics Corp | Nouri Alaleh | EVP, CLO, CORP. SEC. | S - Sale+OE | $23.70 | -6,892 | 114,264 | -6% | -$163,353 | |||||
| D | 2026-03-06 | PRCT | Procept Biorobotics Corp | Waters Kevin | EVP, CFO | S - Sale+OE | $23.70 | -6,721 | 152,264 | -4% | -$159,300 | |||||
2026-03-06 | IRMD | Iradimed Corp | Susi Roger E. | CEO, Pres, COB, 10% | S - Sale | $98.39 | -7,500 | 4,480,450 | 0% | -$737,919 | ||||||
2026-03-05 | TNDM | Tandem Diabetes Care Inc | Novara Mark David | EVP, CHIEF COMMERCIAL OFFICER | S - Sale | $22.81 | -2 | 35,969 | 0% | -$46 | ||||||
2026-03-05 | ATEC | Alphatec Holdings, Inc. | Marshall Tyson Eliot | GC, CORP. SEC. | S - Sale | $12.49 | -88,835 | 559,459 | -14% | -$1,109,549 | ||||||
2026-03-05 | HTFL | Heartflow, Inc. | Cullivan Julie A | Dir | S - Sale | $25.00 | -9,122 | 27,291 | -25% | -$228,050 | ||||||
2026-03-04 | STIM | Neuronetics, Inc. | Macan William Andrew | EVP, CLO, CS | S - Sale | $1.34 | -609 | 879,525 | 0% | -$816 | ||||||
2026-03-06 | DCTH | Delcath Systems, Inc. | Pennell Sandra | CFO | P - Purchase | $9.04 | +5,533 | 77,018 | +8% | +$50,018 | ||||||
| M | 2026-03-04 | OFIX | Orthofix Medical Inc. | Andrews Julie | CFO | S - Sale | $12.74 | -4,788 | 88,746 | -5% | -$60,980 | |||||
| M | 2026-03-04 | OFIX | Orthofix Medical Inc. | Vitale Lucas | CP, BOO | S - Sale | $12.74 | -2,312 | 164,718 | -1% | -$29,445 | |||||
| M | 2026-03-04 | OFIX | Orthofix Medical Inc. | Calafiore Massimo | Pres, CEO | S - Sale | $12.74 | -12,220 | 320,136 | -4% | -$155,633 | |||||
| M | 2026-03-04 | OFIX | Orthofix Medical Inc. | Fisher Patrick | Pres, Global Limb Recon | S - Sale | $12.74 | -1,536 | 50,633 | -3% | -$19,562 | |||||
| M | 2026-03-04 | OFIX | Orthofix Medical Inc. | McPherron Aviva | Pres, Global Ops, Qual | S - Sale | $12.74 | -2,559 | 67,853 | -4% | -$32,591 | |||||
| M | 2026-03-04 | OFIX | Orthofix Medical Inc. | Reinhardt Max | Pres, Global Spine | S - Sale | $12.74 | -2,133 | 25,348 | -8% | -$27,166 | |||||
| M | 2026-03-04 | OFIX | Orthofix Medical Inc. | Cedron Jorge Andres | CLO | S - Sale | $12.74 | -2,775 | 62,749 | -4% | -$35,342 | |||||
2026-03-04 | BBNX | Beta Bionics, Inc. | Hopman Mark | Chief Commercial Officer | S - Sale | $11.57 | -353 | 139,133 | 0% | -$4,084 | ||||||
2026-03-04 | NVCR | Novocure Ltd | Leupin Nicolas | Former Chief Medical Officer | S - Sale | $13.31 | -1,100 | 102,979 | -1% | -$14,636 | ||||||
| D | 2026-03-04 | NVCR | Novocure Ltd | Weinberg Uri | Chf Medical, Innovation Ofr | S - Sale+OE | $13.31 | -6,412 | 267,190 | -2% | -$85,314 | |||||
| D | 2026-03-04 | NVCR | Novocure Ltd | Brackmann Christoph | CFO | S - Sale+OE | $13.31 | -6,412 | 182,842 | -3% | -$85,314 | |||||
| D | 2026-03-04 | NVCR | Novocure Ltd | Leonard Frank X | CEO | S - Sale+OE | $13.31 | -5,607 | 493,793 | -1% | -$74,603 | |||||
| DM | 2026-03-04 | NVCR | Novocure Ltd | Paravasthu Mukund | COO | S - Sale+OE | $13.72 | -48,623 | 72,832 | -40% | -$667,214 | |||||
| D | 2026-03-04 | NVCR | Novocure Ltd | Puri Michal Nath | CHRO | S - Sale+OE | $13.31 | -1,100 | 201,322 | -1% | -$14,636 | |||||
| D | 2026-03-03 | NVCR | Novocure Ltd | Doyle William F | Exec COB | S - Sale+OE | $12.98 | -71,887 | 328,397 | -18% | -$932,883 | |||||
2026-03-04 | RMD | Resmed Inc | Farrell Peter C | Dir | S - Sale | $260.22 | -2,000 | 62,773 | -3% | -$520,440 | ||||||
2026-03-02 | PEN | Penumbra Inc | Yuen Maggie | CFO | S - Sale | $342.30 | -2,432 | 18,353 | -12% | -$832,474 | ||||||
2026-03-02 | LUNG | Pulmonx Corp | Radhakrishnan Srikanth | Chief Science,Techn. Officer | S - Sale | $1.43 | -10,483 | 345,736 | -3% | -$14,991 | ||||||
2026-03-02 | LUNG | Pulmonx Corp | French Glendon E. III | Pres, CEO | S - Sale | $1.43 | -67,813 | 2,152,509 | -3% | -$96,973 | ||||||
2026-03-02 | LUNG | Pulmonx Corp | Rose Geoffrey Beran | Chief Commercial Officer | S - Sale | $1.43 | -7,732 | 465,734 | -2% | -$11,057 | ||||||
2026-03-02 | LUNG | Pulmonx Corp | Lehman David Aaron | GC | S - Sale | $1.43 | -12,237 | 390,755 | -3% | -$17,499 | ||||||
2026-03-03 | AORT | Artivion, Inc. | Horton Amy | VP, Chief Accounting Officer | S - Sale | $37.78 | -901 | 139,088 | -1% | -$34,036 | ||||||
| M | 2026-03-03 | AORT | Artivion, Inc. | Holloway Jean F | SVP, GC | S - Sale | $37.93 | -12,805 | 185,095 | -6% | -$485,728 | |||||
2026-03-03 | AORT | Artivion, Inc. | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $37.78 | -2,149 | 60,097 | -3% | -$81,180 | ||||||
2026-03-03 | AORT | Artivion, Inc. | Davis John E | Chief Commercial Officer | S - Sale | $37.78 | -4,573 | 230,794 | -2% | -$172,748 | ||||||
2026-03-03 | AORT | Artivion, Inc. | Berry Lance A | EVP, COO, CFO, Treasurer | S - Sale | $37.78 | -6,316 | 210,827 | -3% | -$238,591 | ||||||
2026-03-03 | AORT | Artivion, Inc. | Mackin James P | Pres, CEO | S - Sale | $37.78 | -17,887 | 947,275 | -2% | -$675,692 | ||||||
2025-12-15 | NPCE | Neuropace Inc | Morrell Martha | CHIEF MEDICAL OFFICER | S - Sale | $15.97 | -25,000 | 48,624 | -34% | -$399,250 | ||||||
| D | 2026-03-02 | CARL | Carlsmed, Inc. | Cordonnier Michael | CEO, Pres | S - Sale+OE | $13.29 | -197,855 | 1,550,477 | -11% | -$2,629,889 | |||||
| D | 2026-03-02 | BBNX | Beta Bionics, Inc. | Hopman Mark | Chief Commercial Officer | S - Sale+OE | $12.36 | -834 | 139,486 | -1% | -$10,310 | |||||
| D | 2026-03-02 | BBNX | Beta Bionics, Inc. | Russell Steven Jon | Chief Medical Officer | S - Sale+OE | $12.36 | -1,026 | 179,096 | -1% | -$12,683 | |||||
| D | 2026-03-02 | BBNX | Beta Bionics, Inc. | Mensinger Mike | Chief Product Officer | S - Sale+OE | $12.36 | -1,064 | 188,793 | -1% | -$13,153 | |||||
| D | 2026-03-02 | BBNX | Beta Bionics, Inc. | Feider Stephen | CFO | S - Sale+OE | $12.36 | -1,428 | 172,729 | -1% | -$17,652 | |||||
| D | 2026-03-02 | BBNX | Beta Bionics, Inc. | Saint Sean | Pres, CEO | S - Sale+OE | $12.36 | -3,384 | 437,809 | -1% | -$41,832 | |||||
2026-03-02 | IRTC | Irhythm Holdings, Inc. | Turakhia Minang | CHIEF MED, SCI OFCR EVP ADVTEC | S - Sale | $128.45 | -4,027 | 54,906 | -7% | -$517,259 | ||||||
2026-03-02 | IRTC | Irhythm Holdings, Inc. | Shrishrimal Sumi | EVP, Chief Risk Officer | S - Sale | $128.44 | -2,830 | 41,870 | -6% | -$363,484 | ||||||
2026-03-02 | IRTC | Irhythm Holdings, Inc. | Smith Mervin | EVP Strategic Business Ops | S - Sale | $128.44 | -1,352 | 25,612 | -5% | -$173,652 | ||||||
2026-03-02 | IRTC | Irhythm Holdings, Inc. | Patterson Chad | CHIEF COMM, PRODUCT OFFICER | S - Sale | $128.44 | -4,444 | 58,164 | -7% | -$570,804 | ||||||
2026-03-02 | IRTC | Irhythm Holdings, Inc. | Murphy Patrick Michael | CBO, CLO | S - Sale | $128.44 | -4,357 | 63,203 | -6% | -$559,624 | ||||||
2026-03-02 | IRTC | Irhythm Holdings, Inc. | Rosenbaum Marc Wade | Chief Accounting Officer | S - Sale | $128.45 | -816 | 16,706 | -5% | -$104,815 | ||||||
2026-03-02 | IRTC | Irhythm Holdings, Inc. | Wilson Daniel G. | CFO | S - Sale | $128.45 | -3,395 | 35,760 | -9% | -$436,076 | ||||||
2026-03-02 | IRTC | Irhythm Holdings, Inc. | Blackford Quentin S. | Pres, CEO | S - Sale | $128.44 | -13,813 | 204,155 | -6% | -$1,774,174 | ||||||
| D | 2026-03-02 | CVRX | Cvrx, Inc. | Hykes Kevin | PRES, CEO | S - Sale+OE | $7.90 | -7,763 | 284,237 | -3% | -$61,349 | |||||
| D | 2026-03-02 | CVRX | Cvrx, Inc. | Verrastro Paul | CHIEF MKTG, STRAT OFFICER | S - Sale+OE | $7.90 | -1,284 | 60,551 | -2% | -$10,146 | |||||
| D | 2026-03-02 | CVRX | Cvrx, Inc. | Oasheim Jared | CFO | S - Sale+OE | $7.90 | -1,744 | 96,703 | -2% | -$13,781 | |||||
| D | 2026-03-02 | CVRX | Cvrx, Inc. | John Robert Allen | Chief Revenue Officer | S - Sale+OE | $7.90 | -3,964 | 86,036 | -4% | -$31,326 | |||||
2026-03-02 | RMD | Resmed Inc | Sandercock Brett | CFO | S - Sale | $254.30 | -1,000 | 84,495 | -1% | -$254,300 | ||||||
| M | 2026-02-27 | NVCR | Novocure Ltd | Weinberg Uri | Chf Medical, Innovation Ofr | S - Sale | $13.68 | -10,733 | 223,477 | -5% | -$146,863 | |||||
2026-02-27 | NVCR | Novocure Ltd | Puri Michal Nath | CHRO | S - Sale | $13.66 | -1,441 | 162,322 | -1% | -$19,690 | ||||||
2026-03-02 | AORT | Artivion, Inc. | Horton Amy | VP, Chief Accounting Officer | S - Sale | $38.02 | -641 | 132,514 | 0% | -$24,374 | ||||||
2026-03-02 | AORT | Artivion, Inc. | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $38.02 | -1,513 | 40,408 | -4% | -$57,532 | ||||||
2026-03-02 | AORT | Artivion, Inc. | Mackin James P | Pres, CEO | S - Sale | $38.02 | -14,911 | 848,214 | -2% | -$566,989 | ||||||
2026-03-02 | AORT | Artivion, Inc. | Holloway Jean F | SVP, GC | S - Sale | $38.02 | -2,183 | 170,105 | -1% | -$83,008 | ||||||
2026-03-02 | AORT | Artivion, Inc. | Berry Lance A | EVP, COO, CFO, Treasurer | S - Sale | $38.02 | -5,178 | 176,269 | -3% | -$196,893 | ||||||
2026-03-02 | AORT | Artivion, Inc. | Davis John E | Chief Commercial Officer | S - Sale | $38.02 | -2,784 | 206,522 | -1% | -$105,861 | ||||||
| D | 2026-03-01 | NMTC | Neuroone Medical Technologies Corp | Wambeke David J. | Chief Business Officer | P - Purchase | $0.67 | +1,000,000 | 1,000,000 | New | +$670,400 | |||||
| D | 2026-02-27 | LMAT | Lemaitre Vascular Inc | Kamke Trent G | Senior V. P., Operations | S - Sale+OE | $110.29 | -1,044 | 6,677 | -14% | -$115,143 | |||||
| D | 2026-02-27 | LMAT | Lemaitre Vascular Inc | Roberts David B | Pres, Dir | S - Sale+OE | $106.80 | -8,464 | 17,979 | -32% | -$903,958 | |||||
| DM | 2026-02-26 | LMAT | Lemaitre Vascular Inc | Lemaitre George W | COB, CEO | S - Sale+OE | $107.04 | -205,930 | 1,509,900 | -12% | -$22,043,375 | |||||
2026-03-02 | INFU | Infusystem Holdings, Inc | Steele Barry G | EVP, CFO | P - Purchase | $9.16 | +2,064 | 173,936 | +1% | +$18,906 | ||||||
| D | 2026-02-25 | GMED | Globus Medical Inc | Huller Kelly | EVP, GC, Corporate Secretary | S - Sale+OE | $94.50 | -20,000 | 0 | -100% | -$1,890,000 | |||||
2026-02-26 | BDX | Becton Dickinson & Co | Feld Michael | EVP, Chief Revenue Officer | S - Sale | $181.84 | -75 | 21,308 | 0% | -$13,638 | ||||||
2026-02-26 | STIM | Neuronetics, Inc. | Macan William Andrew | EVP, CLO, CS | S - Sale | $1.35 | -3,427 | 880,134 | 0% | -$4,626 | ||||||
2026-02-26 | STIM | Neuronetics, Inc. | Sullivan Keith J | Pres, CEO | S - Sale | $1.35 | -8,452 | 1,524,713 | -1% | -$11,410 | ||||||
2026-02-25 | IRTC | Irhythm Holdings, Inc. | Wilson Daniel G. | CFO | S - Sale | $135.42 | -5,188 | 30,794 | -14% | -$702,553 | ||||||
2026-02-25 | IRTC | Irhythm Holdings, Inc. | Turakhia Minang | CHIEF MED, SCI OFCR EVP ADVTEC | S - Sale | $135.42 | -7,804 | 48,899 | -14% | -$1,056,809 | ||||||
2026-02-25 | IRTC | Irhythm Holdings, Inc. | Smith Mervin | EVP Strategic Business Ops | S - Sale | $135.42 | -4,041 | 20,275 | -17% | -$547,228 | ||||||
| M | 2026-02-24 | OFIX | Orthofix Medical Inc. | Engine Capital Management, LP | 10% | P - Purchase | $12.59 | +137,858 | 4,390,779 | +3% | +$1,734,956 | |||||
2026-02-25 | IRTC | Irhythm Holdings, Inc. | Shrishrimal Sumi | EVP, Chief Risk Officer | S - Sale | $135.42 | -6,217 | 39,182 | -14% | -$841,899 | ||||||
2026-02-25 | IRTC | Irhythm Holdings, Inc. | Rosenbaum Marc Wade | Chief Accounting Officer | S - Sale | $135.42 | -4,797 | 15,014 | -24% | -$649,604 | ||||||
2026-02-25 | IRTC | Irhythm Holdings, Inc. | Patterson Chad | CHIEF COMM, PRODUCT OFFICER | S - Sale | $135.42 | -8,967 | 51,738 | -15% | -$1,214,301 | ||||||
2026-02-25 | IRTC | Irhythm Holdings, Inc. | Murphy Patrick Michael | CBO, CLO | S - Sale | $135.42 | -7,805 | 60,536 | -11% | -$1,056,945 | ||||||
2026-02-25 | IRTC | Irhythm Holdings, Inc. | Blackford Quentin S. | Pres, CEO | S - Sale | $135.42 | -25,540 | 186,126 | -12% | -$3,458,599 | ||||||
2026-02-24 | TCMD | Tactile Systems Technology Inc | Dodd Sheri Louise | CEO | S - Sale | $28.94 | -10,993 | 243,885 | -4% | -$318,144 | ||||||
2026-02-24 | TCMD | Tactile Systems Technology Inc | Birkemeyer Elaine M. | CFO | S - Sale | $28.94 | -7,701 | 134,819 | -5% | -$222,880 | ||||||
2026-02-24 | TCMD | Tactile Systems Technology Inc | Burns Kristie | SVP Mktg, Clinical Affairs | S - Sale | $28.94 | -6,246 | 82,581 | -7% | -$180,764 | ||||||
2026-02-25 | CLPT | Clearpoint Neuro, Inc. | Burnett Joseph | CEO, Pres | S - Sale | $15.17 | -19,951 | 205,730 | -9% | -$302,657 | ||||||
2026-02-24 | SRTS | Sensus Healthcare, Inc. | Sachetta Eric | Dir | P - Purchase | $3.81 | +2,000 | 142,113 | +1% | +$7,620 | ||||||
2026-02-25 | PODD | Insulet Corp | Minogue Michael R | Dir | P - Purchase | $246.23 | +2,030 | 18,261 | +13% | +$499,847 | ||||||
2026-02-24 | IRTC | Irhythm Holdings, Inc. | Rosenbaum Marc Wade | Chief Accounting Officer | S - Sale | $140.91 | -280 | 10,601 | -3% | -$39,455 | ||||||
2026-02-24 | IRTC | Irhythm Holdings, Inc. | Smith Mervin | EVP Strategic Business Ops | S - Sale | $140.91 | -732 | 15,106 | -5% | -$103,146 | ||||||
| M | 2026-02-23 | AORT | Artivion, Inc. | Horton Amy | VP, Chief Accounting Officer | S - Sale | $36.97 | -2,561 | 133,155 | -2% | -$94,690 | |||||
| M | 2026-02-23 | AORT | Artivion, Inc. | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $36.94 | -3,682 | 41,921 | -8% | -$136,013 | |||||
| M | 2026-02-23 | AORT | Artivion, Inc. | Holloway Jean F | SVP, GC | S - Sale | $36.92 | -4,747 | 172,288 | -3% | -$175,269 | |||||
| M | 2026-02-23 | AORT | Artivion, Inc. | Mackin James P | Pres, CEO | S - Sale | $36.83 | -34,898 | 863,125 | -4% | -$1,285,337 | |||||
| M | 2026-02-23 | AORT | Artivion, Inc. | Berry Lance A | EVP, COO, CFO, Treasurer | S - Sale | $36.69 | -9,466 | 181,447 | -5% | -$347,309 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |